Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Integritas Communications

Novel Nonstatin LDL-C Targets in High-Risk Patients

Access Activity

Overview / Abstract:

This CME-accredited CME Snapshotâ„¢ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholesterol (LDL-C) levels using nonstatin lipid-lowering medications, including inhibitors of the enzyme protein convertase subtilisin/kexin type 9 (PCSK9).


Aug 14, 2019


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME


Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Christie M. Ballantyne, MD, FACP, FACC; Marc S. Sabatine, MD, MPH

Sponsors / Supporters / Grant Providers

Jointly provided by the Elsevier Office of Continuing Medical Education and Integritas Communications

These activities have been supported by an independent educational grant from Sanofi US and Regeneron Pharmaceuticals.

Keywords / Search Terms

Integritas Communications Lipids, SLE, Free, CE, CME, LDL-C, Nonstatin, Integritas communications, credits Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.